Literature DB >> 20642331

Region-specific genetic heterogeneity of HBB mutation distribution in South-Western Greece.

Adamantia Papachatzopoulou1, Alexandra Kourakli, Eleana F Stavrou, Ekaterini Fragou, Apostolos Vantarakis, George P Patrinos, Aglaia Athanassiadou.   

Abstract

beta-Thalassemia (beta-thal), is caused by reduced or absent synthesis of beta-globin chains resulting in impaired erythropoiesis. It is the most common single gene defect disease in Greece, with heterozygous rates reaching, on average, 8% in the general population. Here, we performed molecular analyses on 199 unrelated beta-thal and compound beta-thal/sickle cell disease patients, of whom 157 originated from three prefectures of South-Western Greece, namely Achaia, Ilia and Etoloakarnania. Our results indicate that the frequency of specific HBB gene mutations, namely the HBB:c.118C>T (codon 39, C>T), HBB:c.92+6T>C (IVS-I-6, T>C), and HBB:c.20A>T [Hb S, beta6(A3)Glu-->Val, GAG>GTG], present distinct distribution patterns in the Achaia and Ilia prefectures (p < 0.001, p < 0.003 and p < 0.002, respectively). This detailed analysis of the distribution of the HBB gene mutations is useful for genetic counseling in the region, and illustrates that the identification of the HBB gene mutation spectrum in this region is necessary for population carrier screening and for efficient provision of prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642331     DOI: 10.3109/03630269.2010.486354

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.

Authors:  Konstantinos Mitropoulos; Federico Innocenti; Ron H van Schaik; Alexander Lezhava; Giannis Tzimas; Panagoula Kollia; Milan Macek; Paolo Fortina; George P Patrinos
Journal:  Pharmacogenomics       Date:  2012-03       Impact factor: 2.533

2.  Recommendations for genetic variation data capture in developing countries to ensure a comprehensive worldwide data collection.

Authors:  George P Patrinos; Jumana Al Aama; Aida Al Aqeel; Fahd Al-Mulla; Joseph Borg; Andrew Devereux; Alex E Felice; Finlay Macrae; Makia J Marafie; Michael B Petersen; Ming Qi; Rajkumar S Ramesar; Joel Zlotogora; Richard G H Cotton
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

3.  Comparative effects of three iron chelation therapies on the quality of life of greek patients with homozygous transfusion-dependent Beta-thalassemia.

Authors:  Vasilis Goulas; Alexandra Kourakli-Symeonidis; Charalambos Camoutsis
Journal:  ISRN Hematol       Date:  2012-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.